Tags

Type your tag names separated by a space and hit enter

[Ambulatory therapy of trichomoniasis vaginalis. Clinical trial of a new Trichomonas-active azide substance].
Fortschr Med 1976; 94(16):339-42FM

Abstract

Report on the results of the clinical trial of a new trichomonacide in ambulatory patients in a gynaecological practice. A report is given on a new drug for the treatment of vaginal trichomoniasis, which has been tried in 87 patients of a gynaecological practice under outpatient conditions. The rate of failures was 5.7% (5 of 87 cases). The advantages over alternative preparations is to be seen in the short duration of treatment (24 hours at the most), and in the favourable tolerance in spite of high doses.

Authors

No affiliation info available

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

ger

PubMed ID

4370

Citation

Hartung, F. "[Ambulatory Therapy of Trichomoniasis Vaginalis. Clinical Trial of a New Trichomonas-active Azide Substance]." Fortschritte Der Medizin, vol. 94, no. 16, 1976, pp. 339-42.
Hartung F. [Ambulatory therapy of trichomoniasis vaginalis. Clinical trial of a new Trichomonas-active azide substance]. Fortschr Med. 1976;94(16):339-42.
Hartung, F. (1976). [Ambulatory therapy of trichomoniasis vaginalis. Clinical trial of a new Trichomonas-active azide substance]. Fortschritte Der Medizin, 94(16), pp. 339-42.
Hartung F. [Ambulatory Therapy of Trichomoniasis Vaginalis. Clinical Trial of a New Trichomonas-active Azide Substance]. Fortschr Med. 1976 Feb 19;94(16):339-42. PubMed PMID: 4370.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Ambulatory therapy of trichomoniasis vaginalis. Clinical trial of a new Trichomonas-active azide substance]. A1 - Hartung,F, PY - 1976/2/19/pubmed PY - 1976/2/19/medline PY - 1976/2/19/entrez SP - 339 EP - 42 JF - Fortschritte der Medizin JO - Fortschr. Med. VL - 94 IS - 16 N2 - Report on the results of the clinical trial of a new trichomonacide in ambulatory patients in a gynaecological practice. A report is given on a new drug for the treatment of vaginal trichomoniasis, which has been tried in 87 patients of a gynaecological practice under outpatient conditions. The rate of failures was 5.7% (5 of 87 cases). The advantages over alternative preparations is to be seen in the short duration of treatment (24 hours at the most), and in the favourable tolerance in spite of high doses. SN - 0015-8178 UR - https://www.unboundmedicine.com/medline/citation/4370/[Ambulatory_therapy_of_trichomoniasis_vaginalis._Clinical_trial_of_a_new_Trichomonas-active_azide_substance] L2 - https://medlineplus.gov/trichomoniasis.html DB - PRIME DP - Unbound Medicine ER -